Accomplished pharmaceutical professional with more than 35 years of experience in the design and development of novel drug delivery systems from initial concept through regulatory approval. Innovator with extensive patent portfolio and publication record on novel formulations, treatments, and delivery technologies for the administration of small molecules, biologics, and combination products. Proven track record in assembling and leading multidisciplinary teams to drive innovation.
Jeff has published more than 100 peer reviewed papers (h-index = 58), has authored several book chapters, and been invited to speak at many national and international meetings. He is a prolific inventor with 72 issued US patents and more than 300 issued patents worldwide. Jeff’s inventions have resulted in ten approved products and numerous others that are in clinical development. His patented technologies include a blood substitute (Oxygent™), an ultrasound contrast agent (Imagent®), a ventilation technique termed partial liquid ventilation (LiquiVent®), a hydrogel to prevent post-operative adhesions (FloGel®), and numerous patents related to engineered particles for inhalation (e.g., the PulmoSphere™ technology) which is utilized in inhaled drug products including TOBI® Podhaler™ (Viatris), Bevespi® Aerosphere (AZ), Breztri® Aerosphere (AZ), Symbicort® Aerosphere (AZ), AIRSUPRA® (AZ) and Ciprofloxacin DPI (Bayer). Patents are also directed to aerosol delivery of antimicrobials utilizing combinations of liposome encapsulated and free drug (e.g., Arikayce®, Insmed). His design of molecular solutions of drugs in semi-fluorinated alkanes is utilized in Meibo ®and Vevye® products for the treatment of dry eye disease. Currently, these products generate yearly sales in excess of $3B.
Jeff has received numerous awards including RDD’s Charles G. Thiel Award and the Alexander Fleming Serendipity Award from the London Business School, and the Career Achievement Award from the International Society for Aerosols in Medicine (ISAM). He is a Fellow of ISAM and the American Association of Pharmaceutical Scientists (AAPS) and is an Associate Editor for Frontiers in Drug Delivery, while serving on the Editorial Board of the J Aerosol Med Pulm Drug Deliv.